abolished the effects of hBest1 on Ca V 1.3. The effect was specific to hBest1; it was not observed with mouse Best1 (mBest1), mBest2, or mBest3. Wild-type hBest1 and the disease-causing mutants R92S, G299R, and D312N inhibited Ca V currents the same amount, whereas the A146K and G222E mutants were less effective. We propose that hBest1 regulates Ca V channels by interacting with the Ca V ␤ subunit and altering channel availability. Our findings reveal a novel function of bestrophin in regulation of Ca V channels and suggest a possible mechanism for the role of hBest1 in macular degeneration.
Introduction
The human Best1 gene (hBest1) encodes the founding member of a protein family called "bestrophins" (Marquardt et al., 1998; Petrukhin et al., 1998; Hartzell et al., 2008) . hBest1 protein is highly expressed in the basolateral plasma membrane of retinal pigment epithelium (RPE) (Marmorstein et al., 2000) . Mutations in hBest1 are linked to several kinds of macular degeneration, including Best vitelliform macular dystrophy (BVMD) (Marquardt et al., 1998; Petrukhin et al., 1998) , adult-onset vitelliform dystrophy (Kramer et al., 2000; Seddon et al., 2001) , autosomal dominant vitreoretinochoroidopathy (Yardley et al., 2004) , and canine multifocal retinopathy (Guziewicz et al., 2007) .
Considerable evidence supports the idea that bestrophins are Cl Ϫ channels (Hartzell et al., 2008) . RNA interference knockdown of bestrophins in Drosophila S2 cells (Chien et al., 2006; Chien and Hartzell, 2007) and in epithelial cells (Kunzelmann et al., 2007; Barro Soria et al., 2008) reduces endogenous Cl Ϫ currents. Furthermore, overexpression of bestrophins in cell lines induces novel Cl Ϫ currents (Sun et al., 2002; Qu et al., 2003 Qu et al., , 2006b Tsunenari et al., 2003; . hBest1 Cl Ϫ current is dependent on intracellular Ca 2ϩ (EC 50 , ϳ150 nM). Because virtually all disease-causing mutations examined affect hBest1 Cl Ϫ channel function (Sun et al., 2002; Yu et al., 2006 Yu et al., , 2007 , the simplest hypothesis is that macular degeneration is caused by Cl Ϫ channel dysfunction. However, experiments with knock-out mice suggest that this explanation is incomplete (for review, see Hartzell et al., 2008) . Although humans with BVMD have a decreased electro-oculogram light peak (LP) that is thought to be mediated by Ca 2ϩ -activated hBest1 Cl Ϫ channels in the RPE, mice with the mouse Best1 (mBest1) gene disrupted (mBest1 Ϫ/Ϫ ) exhibit normal LP amplitudes at saturating light intensity (Marmorstein et al., 2006) . Furthermore, Ca 2ϩ -dependent Cl Ϫ currents in the knock-out are the same as wild type (wt) (Marmorstein et al., 2006) . This shows that mBest1 is not responsible for the Ca 2ϩ -activated Cl Ϫ current and does not generate the LP. However, mice with the Ca 2ϩ channel Ca V ␣ 1.3 or Ca V ␤ 4 subunits knocked out have significantly reduced LPs, suggesting that the LP relies on voltage-gated Ca 2ϩ channels (Marmorstein et al., 2006; Wu et al., 2007) . These results, coupled with the finding that hBest1 overexpression alters the kinetics of endogenous voltage-gated Ca 2ϩ channels in RPE-J cells (Rosenthal et al., 2005) , have led to the proposal that hBest1 is not a Cl Ϫ channel but rather a regulator of Ca 2ϩ signaling (Marmorstein et al., 2006) . This raises the question whether diseasecausing mutations in hBest1 impair not only Cl Ϫ channel function but also affect voltage-gated Ca 2ϩ channels. Freshly isolated human RPE cells express the L-type Ca V channel ␣ subunits ␣1.2 and ␣1.3 and ␤ subunits ␤2 and ␤4 (Wimmers et al., 2008) . Here, we examine the effect of hBest1 expression on Ca V 1.3 L-type channels and have found hBest1 regulates channel function via ␤ subunits. Several disease-causing mutations that disrupt Cl Ϫ channel function do not abolish the inhibitory effect on Ca V channels. However, some mutations, notably G222E and A146K, are less effective in inhibiting Ca V channels than wild-type hBest1.
Materials and Methods
Constructs and molecular biology. hBest1 tagged with the myc epitope at the C terminus in pRK5 was obtained from Dr. Jeremy Nathans (Johns Hopkins University, Baltimore, MD) (Sun et al., 2002) . Site-specific mutations were generated using PCR-based mutagenesis (Quickchanger; Stratagene) (Qu et al., 2006b) . Channel fragments were generated by PCR using Pfx polymerase and confirmed by sequencing. cDNAs encoding Ca V subunits were as follows: rat ␣ 1 1.3 (GenBank accession number AF370010; provided by Dr. Diane Lipscombe, Brown University, Providence, RI) (Helton et al., 2005) ; FLAG-tagged ␣ 1 1.3 (Calin-Jageman et al., 2007) ; FLAG-tagged ␤ 2a (Zhou et al., 2004) ; ␤ 1b (GenBank accession number NM017346); ␤ 2a (GenBank accession number NM053581); ␤ 4 (GenBank accession number L02315; provided by Dr. E. Perez-Reyes, University of Virginia, Charlottesville, VA); and ␣ 2 ␦ (GenBank accession number M21948). For pull-down assays, glutathione S-transferase (GST)-tagged ␤ 2a fusion protein was used (Roger Colbran, Vanderbilt University Medical Center, Nashville, TN) (Grueter et al., 2006) .
Cell culture and transfection. Human embryonic kidney (HEK) cells were cultured as described previously (Yu et al., 2006) . For electrophysiology, low-passage HEK293 cells were transiently transfected using Fugene-6 (Roche Diagnostics) with ϳ4 g of total DNA consisting of a mixture of ␣ 1 1.3 (1.5 g); ␤ 1b , ␤ 2a , or ␤ 4 (0.8 g); and ␣ 2 ␦ (0.8 g), with or without hBest1 (0.5 g) per 35 mm dish. Cells were also transfected with pEGFP (0.1 g) for fluorescent detection of transfected cells. RPE-J cells (American Type Culture Collection) were cultured in DMEM supplemented with 4% fetal calf serum at 32°C and 5% CO 2 in air. The 60 -80% confluent cells were transfected with Lipofectamine (Invitrogen) according to manufacturer instructions. The total amount of DNA per dish (35 mm) was 2 g. Cotransfection of wild type or mutant hBest1 with enhanced green fluorescent protein was performed at a ratio of 5:1. Transfected cells were plated at low density and used 24 -72 h later.
Electrophysiology. Cells were whole-cell patch clamped with a HEKA Elektronik EPC-7 patchclamp amplifier. Clampfit Software (Molecular Devices) was used for data acquisition and leak subtraction using a P/Ϫ4 protocol. The standard pipette solution contained the following (in mM): 146 CsCl, 2 MgCl 2 , 2 Mg-ATP, 5 EGTA, 8 HEPES, pH 7.3, adjusted with N-methyl-D-glucamine. The "high" Ca 2ϩ pipette solution used for recording Cl Ϫ current contained 5 mM (Ca 2ϩ )-EGTA instead of EGTA, which supplied free Ca 2ϩ of ϳ10 M. The standard extracellular solution contained the following (in mM): 130 NaCl, 3 TEA-Cl, 10 BaCl 2 , 1 MgCl 2 , 10 glucose, 10 HEPES, pH 7.3 with Tris. Osmolarity was adjusted with sucrose to 305 mOsm for all solutions. Electrode resistances were typically 2-3 M⍀ in the bath solution, and series resistance was ϳ2-4 M⍀ compensated up to 80%. For measuring I Ba , a standard I-V protocol with 20 ms step depolarizations (Ϫ70 to ϩ60 mV) was used to evoke currents from a Ϫ80 mV holding potential. Tail currents were measured at Ϫ70 mV. I-V relationships for each cell were fitted to the following equation:
, where I is the whole-cell current density, G is the specific conductance, V rev is the reversal potential, V 1/2 is the voltage of half-maximal activation, and k is a slope factor. Normalized tail current-voltage and steady-state inactivation data were fit with a single Boltzmann function as follows:
where V is test or prepulse voltage, V 1/2 is the midpoint of the activation or inactivation curve, k is a slope factor, A is the amplitude, and b is the baseline. For measuring I Cl , the I-V protocol consisted of 750 ms pulses from a 0 mV holding potential. Data were analyzed with Clampfit 8.2 and Origin 7.0 software. Averaged data are mean Ϯ SEM. Statistical significance was determined by two-way ANOVA or Student's t test.
Coimmunoprecipitation and Western blot. HEK293 cells were transfected with FLAG-Ca V subunits and myc-tagged hBest1 or hBest1-C terminus. Cell lysates were prepared by homogenization in 1 ml of icecold lysis buffer (10 mM HEPES, 50 mM NaCl, 1 mM benzamidine, and 0.5% Triton X-100, pH 7.4) above and incubated with 40 l of anti-FLAG M2 affinity gel (Sigma-Aldrich) for 1 h, rotating at 4°C. After removing the beads by centrifugation and five washes with 1 ml of lysis buffer, proteins were eluted with sample buffer and subjected to SDS-PAGE. Proteins were detected by Western blotting with monoclonal anti-myc or anti-FLAG antibodies (1:2000; Sigma-Aldrich), followed by HRP-secondary antibodies and ECL detection.
Pull-down assay. Fusion proteins were grown in BL21 Escherichia coli, induced by isopropyl-␤-D-thiogalactopyranoside, and purified on glutathione agarose (␤2a) or a Co 2ϩ (hBest1) affinity column. assays (Grueter et al., 2006) , GST-tagged ␤2a or GST (control) were incubated at 4°C for 1 h with myc-tagged hBest1 or hBest1-C terminus in 50 mM Tris-HCl, pH 7.5, 150 mM NaCl, and 0.1% Triton X-100. Glutathione-agarose was added, and the incubation was continued for 1 h. Resin was collected by centrifugation and washed four times in binding buffer. Bound proteins were resolved by SDS-PAGE, transferred to nitrocellulose membranes, and then immunoblotted.
Results
hBest1 specifically reduces Ca V 1.3 current density Different protocols were used to measure Ca 2ϩ currents and Cl Ϫ currents in HEK cells transfected with hBest1 and Ca V subunits ( Fig. 1 A) . hBest1 Cl Ϫ currents were measured with high intracellular free Ca 2ϩ and 0 mV holding potential. The depolarized holding potential (and possibly the high intracellular Ca 2ϩ ) induced Ca V channel inactivation so that the Cl Ϫ current was measured with little contamination from Ca V channels. The Cl Ϫ currents in cells coexpressing Ca V 1.3 plus hBest1 and those expressing hBest1 alone were the same, showing that the Cl Ϫ currents were not contaminated with Ca 2ϩ currents (Fig. 1C,D ). Ca V currents were measured with Ba 2ϩ as charge carrier with nominally zero intracellular free Ca 2ϩ (10 mM EGTA with no added Ca 2ϩ ) from a holding potential of Ϫ80 mV. Under these conditions, hBest1 was not activated, and the Ca V current could be measured with no contamination from hBest1 (Fig. 1C,D) .
Expression of wt hBest1 in HEK293 cells induced Ca 2ϩ -dependent Cl
Ϫ currents with similar amplitudes and biophysical properties when expressed alone or with Ca V channel subunits ␣ 1 1.3/␤ 1b /␣ 2 ␦ (Fig. 1C,D) . Cl Ϫ currents were not observed in cells transfected with Ca V subunits alone (Fig. 1 B) .
In cells cotransfected with ␣ 1 1.3/␤ 1b /␣ 2 ␦ plus hBest1, I Ba was significantly smaller in amplitude compared with I Ba in cells transfected with ␣ 1 1.3/␤ 1b /␣ 2 ␦ alone. The decrease in current amplitude occurred across the entire range of test pulse voltages. Furthermore, there was no change in reversal potential ( Fig.  1 B, C) , indicating hBest1 did not influence the permeation properties of Ca V 1.3. The effects of hBest1 were not caused by a nonspecific decrease in Ca V 1.3 expression as a consequence, for example, of competition for translation machinery because mBest1, mBest2, or mBest3 did not decrease I Ba (Fig. 2) .
Amino acids 330 -370 in the hBest1 C terminus are critical for inhibition of Ca V 1.3 Bestrophins consist of four to six highly conserved transmembrane domains located in the first ϳ295 amino acids and a highly variable cytoplasmic C-terminal domain ( Fig. 3A ) (Tsunenari et al., 2003; Milenkovic et al., 2007) . To identify the region of hBest1 responsible for inhibition of Ca V 1.3, we cotransfected Ca V 1.3 subunits with cDNAs corresponding to either the C-terminal (CT ) or N-terminal (NT 1-289 ) part of hBest1. Neither of these fragments generated Cl Ϫ currents when transfected alone (data not shown). Although hBest1-NT 1-289 did not influence I Ba , hBest1-CT 292-586 caused a similar decrease in I Ba amplitude to that produced by full-length hBest1 ( Fig. 3A-C ). These results demonstrate that inhibition of Ca V 1.3 does not require the Cl Ϫ -conducting properties of hBest1 but relies on determinants in hBest1-CT .
To pinpoint these determinants, we tested the effects of truncated fragments of hBest1-CT (Fig. 4 A) . Peak I Ba densities were significantly reduced by coexpression with C-terminal fragments CT 292-X with X Ն 400. Therefore, amino acids 292-400 of hBest1 contain the region involved in Ca v 1.3 regulation.
The critical region was further refined by expressing N-terminal constructs of hBest1 truncated at positions 380, 370, 360, 350, 340, 330, and 289 (Fig. 4 B) . Significant inhibition was induced by all hBest1-NT fragments truncated beyond 340 (NT 1-X with X Ն 340). However, the inhibition caused by NT 1-340, NT 1-350 , and NT 1-360 was less than that caused by NT 1-370 or longer. NT 1-370 or NT 1-380 exerted the same inhibition as fulllength hBest1. Together, these results suggest that the region from 330 to 370 is important in the regulation of Ca V by hBest1.
Ca V ␤ is required for Ca V 1.3 modulation by hBest1
Because Ca V ␤ auxiliary subunits (Ca V ␤ 1 -Ca V ␤ 4 ) strongly influence Ca V current density and activation properties (Dolphin, 2003) , we tested whether the effect of hBest1 on Ca V 1.3 depended on Ca V ␤. hBest1 inhibited Ca V 1.3 channels containing ␤ 1b , ␤ 2A , or ␤ 4 similarly (Figs. 1 B, D, 5A, B) . However, no inhibition of I Ba by hBest1 was seen on the channel consisting of ␣ 1 1.3/␣ 2 ␦ without a ␤ subunit (Fig. 5C ). Furthermore, hBest1 had no effect on Ca V 3.1 expressed without a ␤ subunit (Table 1) . These results show that Ca V ␤ subunits are required for Ca V 1.3 inhibition by hBest1.
hBest1 inhibits the number of available Ca V 1.3 channels To determine the mechanism of Ca V 1.3 inhibition by hBest1, activation and steady-state inactivation curves were measured by tail current analysis for ␣ 1 1.3/␤ 1b /␣ 2 ␦ expressed with and with- out full-length hBest1 or hBest1-CT (Fig. 6 , Table 1 ). The inactivation curve was not affected by either full-length hBest1 or its C-terminal fragment (Fig. 6 B) . Activation was not significantly affected by the C-terminal fragment but was shifted ϳ8 mV in the depolarizing direction by the full-length hBest1 (Fig.  6 A) . This shift in the activation can also be seen in shift in the peak the I-V curves in Figure 1 , B and C. These data suggest that although the inhibitory effects of hBest1 can be mostly accounted for by structures located in the C terminus, other regions of hBest1 may contribute to other effects. Although full-length hBest1 has small effects on the voltage dependence of channel activation (Table 1) , these effects are not sufficient to explain the effect of hBest1 on I Ba amplitude. In order for the shift in the activation curve to affect peak I Ba amplitude significantly, inactivation would need to occur much more rapidly than it does (Fig.  1) .
The inhibitory effects of hBest1 could be explained by negative regulation of gating or a decrease in the number of available Ca V 1.3 channels. To distinguish between these possibilities, we compared the effects of hBest1 on gating and ionic currents. The whole-cell ionic current ( I) is described by the relationship I ϭ N ϫ i ϫ P o , where N is the number of available channels at the membrane, P o is the channel open probability, and i is the unitary current amplitude. The on gating charge (Q on ) is a useful index of N [Q on ϭ Nq (Wei et al., 1994) ]. We calculated Q on as the time integral of the on gating current isolated at the reversal potential of I Ba (E rev ϭ ϩ60 mV) (Fig. 7 A, B) . hBest1-CT 292-586 caused a similar inhibition of Q on as the whole-cell current (I tail ). The slope of the line provided by a regression of I tail obtained at ϩ60 mV (E rev ) versus Q on provided a measure of relative P o (Fig. 7C) . By this analysis, P o displayed no difference between Ca V 1.3 alone and Ca V 1.3 plus hB1-CT . Because Q on is rather small for hBest1 expressing cells, this measurement is subject to some error and cannot definitively rule out the possibility that hBest1 produces a change in P o . However, the major effect of hBest1 is to reduce the number ( N) of available Ca V 1.3 channels. To determine whether hBest1 interferes with Ca V ␣ 1 1.3 channel expression, we measured the amount of Ca V ␣ 1 1.3 protein in HEK cells transfected with FLAG-tagged ␣ 1 1.3, ␤ 1b , and ␣ 2 ␦ with and without myctagged wt-hBest1 or hB1-CT 292-586 . Western blot with anti-FLAG antibody detected similar levels of expression of FLAG-␣ 1 1.3 (ϳ210 kDa) in all three lysates (Fig. 7D, left  panel) . wt-hBest1 (68 kDa) and hB1-CT (50 kDa) detected with anti-myc antibody were observed only in lysates from cells transfected with wt-hBest1 or hB1-CT (Fig.  7D, right panel) .
Mutation of a proline-rich motif in hBest1 eliminates effects of hBest1 on Ca V 1.3 The C-terminal domain of bestrophins is proline rich and is predicted to contain srchomology (SH3)-binding domains (Hartzell et al., 2008) . Because SH3 domains of Ca V ␤ subunits are essential for their effects on Ca V channel gating and trafficking (Takahashi et al., 2005) , we hypothesized that SH3-binding domains of bestrophins might be required for Ca V modulation. We compared the sequences of several bestrophins and found a unique proline-rich motif ( 330 PXXXP 334 ) in hBest1, which is not present in mBest1, mBest2, or mBest3 (Fig. 8 A) . This region is predicted to be within or immediately flank an SH3-binding domain. To determine whether this domain is responsible for the effects of hBest1, we mutated hBest1 at Pro 330 and Pro 334 and tested the influence of the double mutation P330W/P334W on Ca V 1.3. As shown in Figure 8 , B and C, the mutant had no effect on Ca V 1.3. However, this mutant is expressed at similar levels as wild type and generates normal Cl Ϫ currents (Fig. 8 D, E) .
Ca V ␤ binds to hBest1
Based on our physiological evidence supporting an interaction between hBest1 and Ca V ␤, we tested whether hBest1 physically interacts with Ca V ␤ subunits by coimmunoprecipitation. HEK293 cells were cotransfected with myc-tagged hBest1 and FLAG-tagged ␤ 2a or, as a negative control, untagged ␤ 2a . Anti-FLAG antibodies coimmunoprecipitated FLAG-␤ 2a , and hBest1 from lysates of cells cotransfected with FLAG-␤ 2a and mychBest1, but not from cells cotransfected with untagged ␤ 2a and myc-hBest1 (Fig. 9A) .
To determine which regions of hBest1 were involved in the binding to Ca V ␤, the ability of immobilized GST-␤ 2a to pull down C-terminal fragments of hBest1 from lysates of transfected HEK cells was measured. As shown in Figure 9B , immobilized GST-␤ 2a , but not the GST control, bound to myc-tagged hBest1-CT 292-586 . Furthermore, hBest1-CT 380 -586 did not bind GST-␤ 2a (Fig. 9C) , as expected from the inability of hBest1-CT 380 -586 to inhibit Ca current (Fig. 4) . Surprisingly, both hBest1-CT 352-586 and P330W/ P334W-hBest1, which had no inhibitory effect on Ca current, both bound to GST-␤ 2a beads. These data suggest that, although the effect of hBest1 on Ca current requires amino acids 330 -370 and prolines 330 and 334, binding of hBest1 to Ca V ␤ does not require amino acids 330 -352. However, it should be noted that this assay may not reflect quantitative changes in binding affinity.
Effects of hBest1 on endogenous Ca

2؉
currents in the RPE-J cell line Rosenthal et al. (2005) reported that hBest1 can regulate endogenous Ca 2ϩ channels in RPE-J cells. The molecular identity of the current is not absolutely certain, however. The cells express ␣ 1 1.3 by immunocytochemistry (Wollmann et al., 2006; Wimmers et al., 2008) , but expression of other ␣ and ␤ subunits was not investigated. The current was not shown to exhibit negative activation threshold and limited dihydropyridine sensitivity that defines Ca V 1.3 currents. According to their finding, hBest1 plays a role as Ca 2ϩ channel regulator by shifting the voltage dependence of Ca 2ϩ channel activation to the left and accelerates activation without changing current amplitude. In contrast to the results of Rosenthal et al. (2005) , we found that hBest1 caused a decrease in endogenous Ca 2ϩ current in RPE-J cells with no significant effects on channel voltage dependence (Fig. 10) . These results are very similar to what we have reported above for the effects of hBest1 on Ca V 1.3 expressed in HEK cells. The inhibitory effect is partly eliminated by the disease-causing hBest1 mutant G299R-hBest1 (Fig. 10) .
Effects of hBest1 disease-causing mutations on expressed Ca V currents
To investigate the effect of disease-causing mutations on the regulation of Ca 2ϩ currents by hBest1, we studied the effects of mutants on currents generated by the defined Ca V 1.3 channel (␣ 1 1.3/␤ 1b /␣ 2 ␦) expressed in HEK cells (Fig. 11) . We tested six different mutants: D312N, R92S, G299E, G299R, G222E, and A146K. Tested by Western blot with anti-myc antibody, these mutants are all expressed, although G299R and G299E may be reduced compared with wild-type hBest1 (Fig. 11 A, top) . All of these mutants were either nonfunctional as Cl Ϫ channels or produced Cl Ϫ currents that were significantly smaller than wild type (Fig. 11 A, bottom) . Wild-type hBest1 and the six mutants reduced Ca V current (Fig. 11 B, C) . Although the Ca 2ϩ current density was significantly smaller than control when coexpressed with mutant or wild-type hBest1 ( p Ͻ 0.01), the percentage of inhibition ranged from 85% for wild-type hBest1 to 50% for G222E and A146K. The amount of inhibition produced by the G222E and A146K mutants was significantly less than the inhibition produced by wild-type hBest1 ( p Ͻ 0.05). Because the effect of some of the mutants was quite variable, we quantified the amount of inhibition not only by mean current density but also by the fraction of cells that had current densities smaller than control current amplitude minus three SEMs (Fig. 11C, horizontal line) . Whereas Ͻ7% of control cells had currents smaller than this value, 96% of hBest1 transfected cells had currents below this threshold (Fig. 11 D) . However, for G222E and A146K, only 46% of the cells had currents below this level. These results show that the G222E and A146K mutants were less effective in inhibiting Ca V currents than wild type or the D312N or R92S mutants.
Discussion
The main finding of this study is that hBest1 modulates Ca V 1.3 L-type Ca channels. The inhibitory effect of hBest1 requires the presence of ␤ subunits: the effect is not seen with Ca V 1.3 or Ca V 3.1 expressed in the absence of ␤ subunits. The C-terminal domain of hBest1, especially a proline-rich region located within amino acids 330 -370, is critical for the modulation. The physiological findings are supported by the finding that Ca V ␤ directly binds the C terminus of bestrophin. Several bestrophin homologs, including mBest1, mBest2, and mBest3, do not exert any obvious effect on Ca channel properties, possibly because they lack the proline-rich domain 330 PxxxP 334 . We hypothesize that hBest1 specifically regulates Ca 2ϩ channels by associating with SH3 domains in Ca V ␤ subunits. The data have important impli- cations for not only understanding how bestrophins function but also for describing new mechanistic paradigms for SH3-binding partners controlling Ca channels through Ca V ␤.
Role of hBest1 in RPE
Although these experiments use cells that heterologously express Ca V 1.3 and hBest1, it is very likely that our results are physiologically relevant to RPE cell function. Human RPE cells and the RPE cell line ARPE-19 express Ca V ␣1.3 and ␤2 subunits (Wimmers et al., 2008) . Furthermore, it has been shown recently that hBest1 coimmunoprecipitates with Ca V ␤ subunits from freshly isolated human RPE cells . These results suggest that it is likely that the interaction between hBest1 and Ca V subunits has an important physiological function and may help resolve the present controversy of whether Best1 is a Cl Ϫ channel (Hartzell et al., 2008) .
As reviewed in the Introduction, there is strong evidence that bestrophins are Cl Ϫ channels (Hartzell et al., 2008) , but this idea has been questioned (Marmorstein et al., 2004a (Marmorstein et al., ,b, 2006 Rosenthal et al., 2005; Marmorstein and Kinnick, 2007) . These authors have proposed that hBest1 is not a Cl Ϫ channel but rather is a regulator of Ca 2ϩ signaling (Rosenthal et al., 2005; Marmorstein et al., 2006) . This suggestion is based on the finding that hBest1 overexpression shifts the voltage dependence of Ca 2ϩ channel activation to the left and accelerates activation of endogenous voltage-gated Ca 2ϩ channels in RPE-J cells (Rosenthal et al., 2005) . The W93C mutant shifts voltage dependence of activation to the left and slows inactivation. In contrast, the R218C mutation accelerates and augments Ca 2ϩ current inactivation. The LP of the electrooculogram, which is a hallmark diagnostic feature of BVMD, is apparently dependent on voltage-gated Ca 2ϩ channels in mouse, because the LP is reduced by the Ca 2ϩ channel blocker nimodipine and is abolished in ␤ 4 (Marmorstein et al., 2006) and Ca V ␣1.3 knock-out (Wu et al., 2007) mice. Our results strengthen the suggestion that hBest1 is a multifunctional protein, both a Cl Ϫ channel and a channel regulator. However, it is puzzling that mouse Best1 does not regulate Ca V 1.3, because the study by Marmorstein et al. (2006) in mouse was the motivation for this paper.
Regardless of whether hBest1 functions as a Cl Ϫ channel and/or a Ca 2ϩ -channel regulator, it seems clear that bestrophin participates in epithelial transport across the RPE. How might disrupted epithelial transport be linked to macular degeneration? RPE has a variety of essential functions in retina, including paracrine hormone secretion, participation in the blood-eye barrier, epithelial transport, regeneration of visual pigment, and phagocytosis of photoreceptor outer segments (Strauss, 2005) .
It is well established that RPE Cl Ϫ channels are activated (indirectly) by light (Gallemore et al., 1998) , and it seems likely that these channels correspond to hBest1 (Hartzell et al., 2008) . We propose hBest1 inhibits Ca V channels only when hBest1 is in the closed conformation and that Ca V channels are activated by the conformational change that occurs when hBest1 is activated by light. That is, we imagine that when hBest1 channels are tuned on, hBest1 inhibition of Ca V channels is relieved. The efflux of Cl Ϫ through hBest1 will depolarize the cell to facilitate Ca V channel opening. Ca 2ϩ influx will then augment hBest1 Cl Ϫ current by a positive feedback. Ca 2ϩ influx provides Ca 2ϩ for the many Ca 2ϩ -dependent processes that occur in RPE in light, such as phagocytosis of photoreceptor outer segments and secretion of various paracrine hormones.
Our finding that six hBest1 disease-causing mutants have different abilities to inhibit Ca V 1.3 currents suggests that Ca V channel regulation may not be coupled tightly to Cl Ϫ channel activity. Four of these mutants, D312N, R92S, G299E, and G222E, are also dominant negative on wild-type hBest1 Cl Ϫ channel function: coexpression of these mutants inhibits the currents generated by hBest1 . Although D312N, R92S, and G299E have statistically the same effect on Ca V currents as wild-type hBest1, G222E has a significantly smaller effect. The topological location of G222 in hBest1 is controversial. Tsunenari et al. (2003) place it extracellularly, whereas Milenkovic et al. (2007) place it in the same intracellular loop as A146. The A146K mutation produces measurable Cl Ϫ currents, although they are smaller than wild type, and is not dominant negative . This mutant also has smaller effects on Ca V channels. Although quantitative differences exist between different mutations in their ability to inhibit Ca V currents, our data would be consistent with a model in which BVMD is caused primarily by a defect in Cl Ϫ channel function and not a defect in the ability of hBest1 to regulate Ca V channels. 
SH3-binding partners as modulators of voltage-gated Ca
2؉ channels L-type voltage-gated Ca channels are composed of multiple subunits, the poreforming ␣ 1 subunit and the accessory ␤ and ␣ 2 ␦ subunits (Catterall, 2000) . It is well established that Ca V ␤ subunits modulate Ca V ␣ 1 channel function in multiple ways (Birnbaumer et al., 1998; Dolphin, 2003) . ␤ subunits act as chaperones that are essential for the proper assembly and trafficking of Ca V channels to the plasma membrane. However, in addition, ␤ subunits play a direct modulatory role on the pore-forming ␣ 1 subunit voltage sensitivity and gating. At least some of these direct modulatory effects are mediated by interactions between an SH3 domain linked to a guanylate kinase (GK) domain in the ␤ subunit Opatowsky et al., 2004; Van et al., 2004) . These two domains are required for both the trafficking and gating effects of ␤ subunits, and interactions between the two domains are important in mediating these functions (Takahashi et al., 2005) . Here, we show that the bestrophin SH3-binding domain is crucial for the regulation of Ca V currents and that Ca V ␤ subunits are required for the effect. Both gating currents and kinetics are altered in a way that is consistent with altered Ca V ␤ function by bestrophin. The simplest model that one might imagine could involve hBest1 disrupting the interaction between the SH3 and GK domains of the ␤ subunit (Takahashi et al., 2004 (Takahashi et al., , 2005 .
It is worth noting that all bestrophins have a proline-rich C terminus with several predicted SH3-binding domains. However, the SH3 binding domain that is predicted in hBest1 between amino acids 336 and 350 is not found in the other bestrophins. It is particularly interesting that mouse Best1 lacks this domain and does not regulate the Ca 2ϩ currents. Whether this reflects some mismatch caused by species-specific sequences or reflects a fundamental difference between human and mouse Best1 remains to be determined. It also raises questions about the role of Best1 in mouse and human as discussed above. It is also intriguing that this predicted SH3-binding domain is adjacent to the 358 SFxGS 362 domain that we have shown previously to have important regulatory functions in Best2 and Best3 (Qu et al., 2006a (Qu et al., , 2007 . , and ␣ 1 1.3/␤ 1b /␣ 2 ␦ plus hBest1 (filled circle). Peak Ba 2ϩ currents were measured during 20 ms test step at Ϫ20 mV after 2 s conditioning pulses in the range of Ϫ120 to ϩ40 mV (20 mV increments) and normalized to the largest in the series. 
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